A physiologically based pharmacokinetic (PBPK) model describing the kinetics of a commercial mixture α-, β-, and γ-hexabromocyclododecane exposure in mice
Crossref DOI link: https://doi.org/10.1007/s00204-024-03939-4
Published Online: 2025-01-23
Published Print: 2025-03
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Emond, Claude https://orcid.org/0000-0001-6593-964X
DeVito, Michael J.
Birnbaum, Linda S.
Funding for this research was provided by:
NIH (ZIA BC 011476, HHSN261201800377P)
Text and Data Mining valid from 2025-01-23
Version of Record valid from 2025-01-23
Article History
Received: 8 August 2024
Accepted: 10 December 2024
First Online: 23 January 2025